U.S. Markets open in 8 hrs 36 mins

Amedisys Inc (AMED) Files 10-K for the Fiscal Year Ended on December 31, 2018

- By insider

Amedisys Inc (AMED) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Amedisys Inc is a provider of home health services to the chronic, co-morbid, aging American population. The company's operations include servicing patients through its segments home health, hospice and personal care. Amedisys Inc has a market cap of $3.96 billion; its shares were traded at around $124.30 with a P/E ratio of 47.62 and P/S ratio of 2.58.

For the last quarter Amedisys Inc reported a revenue of $434.4 million, compared with the revenue of $404.2 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $1.7 billion, an increase of 8.4% from last year. For the last five years Amedisys Inc had an average revenue growth rate of 6.7% a year.

The reported diluted earnings per share was $3.55 for the year, an increase of 303.4% from previous year. The Amedisys Inc had an operating margin of 9.33%, compared with the operating margin of 7.08% a year before. The 10-year historical median operating margin of Amedisys Inc is 4.81%. The profitability rank of the company is 5 (out of 10).

At the end of the fiscal year, Amedisys Inc has the cash and cash equivalents of $20.2 million, compared with $86.4 million in the previous year. The long term debt was $5.78 million, compared with $78.2 million in the previous year. The interest coverage to the debt is at a comfortable level of 21.1. Amedisys Inc has a financial strength rank of 7 (out of 10).

At the current stock price of $124.30, Amedisys Inc is traded at 227.2% premium to its historical median P/S valuation band of $37.99. The P/S ratio of the stock is 2.58, while the historical median P/S ratio is 0.79. The stock gained 109.93% during the past 12 months.

For the complete 20-year historical financial data of AMED, click here.

This article first appeared on GuruFocus.